Gragnoli Claudia
Laboratory of Molecular Genetics of Complex and Monogenic Disorders, Department of Medicine and Cellular & Molecular Physiology and Biostatistics, Penn State University and M. S. Hershey Medical Center, Hershey, Pennsylvania 17033, USA.
Ophthalmic Genet. 2011 Nov;32(4):228-30. doi: 10.3109/13816810.2011.592174. Epub 2011 Jul 5.
Diabetic retinopathy is a long-term complication of type 2 diabetes (T2D). Non-diabetic retinopathy may be present in T2D patients as well and non-T2D patients with hypertension and/or atherosclerosis. The aim of this study was to identify linkage of the proteasome modulator 9 (PSMD9) T2D risk variants IVS3+nt460, IVS3+nt437, E197G to diabetic retinopathy and retinopathy including also atherosclerotic or hypertensive retinopathy in Italian T2D families.
A total of 126 siblings of our 200 T2D siblings/families were characterized for diabetic retinopathy or retinopathy. The clinical characterization is based on a fundus oculi exam and on fluorangiography of the participating subjects. Diabetic retinopathy includes both pre-proliferative and proliferative retinopathy. The common gene variants were directly amplified by PCR and by fluorescent-based automation. A parametric and non-parametric linkage study of the gene variants with diabetic retinopathy and retinopathy was then performed using Merlin software. Finally, 1000 simulation analyses were performed to test for the statistical power of the significant results (P-value ≤ 0.05).
This study shows a linkage of the PSMD9 IVS3+nt460 (rs74421874), IVS3+nt437 (rs3825172) and E197G (rs14259) single nucleotide polymorphisms (SNPs) to diabetic and non-diabetic retinopathy by using the non-parametric as well as the parametric linkage analysis. The strongest signal is present for the PSMD9 variants with the diabetic retinopathy, in particular under the additive model. The 1,000 simulations performed for each significant test confirmed that the results are not due to random chance.
In summary, the PSMD9 IVS3+nt460, IVS3+nt437, E197G SNPs are linked to diabetic retinopathy and non-diabetic retinopathy in Italians.
糖尿病视网膜病变是2型糖尿病(T2D)的一种长期并发症。非糖尿病视网膜病变也可能存在于T2D患者以及患有高血压和/或动脉粥样硬化的非T2D患者中。本研究的目的是在意大利T2D家族中确定蛋白酶体调节剂9(PSMD9)的T2D风险变异体IVS3 + nt460、IVS3 + nt437、E197G与糖尿病视网膜病变以及包括动脉粥样硬化性或高血压性视网膜病变在内的视网膜病变之间的联系。
在我们的200个T2D同胞/家庭中,共有126名同胞接受了糖尿病视网膜病变或视网膜病变的特征分析。临床特征分析基于参与受试者的眼底检查和荧光血管造影。糖尿病视网膜病变包括增殖前期和增殖性视网膜病变。常见基因变异通过聚合酶链反应(PCR)和基于荧光的自动化技术直接扩增。然后使用Merlin软件对基因变异与糖尿病视网膜病变和视网膜病变进行参数和非参数连锁研究。最后,进行了1000次模拟分析以检验显著结果(P值≤0.05)的统计功效。
本研究通过非参数和参数连锁分析表明,PSMD9的IVS3 + nt460(rs74421874)、IVS3 + nt437(rs3825172)和E197G(rs14259)单核苷酸多态性(SNP)与糖尿病性和非糖尿病性视网膜病变有关。PSMD9变异体与糖尿病视网膜病变的信号最强,尤其是在加性模型下。对每个显著检验进行的1000次模拟证实,结果并非由随机因素导致。
总之,PSMD9的IVS3 + nt460、IVS3 + nt437、E197G SNP与意大利人的糖尿病视网膜病变和非糖尿病视网膜病变有关。